Light Chain MGUS Calculator #Onconephrology 🦀 #Nephpearls #NephSky H/T @sabinekaram.bsky.social 📱 istopmm.com/lcmgus/ 👉 pubmed.ncbi.nlm.nih.gov/36100605/

✨ From data to dialogue: Explore kidney care worldwide with the ISN-GKHA Interactive Map 🗺️ 📊 Compare countries 📌 Spot care gaps 🌐 Drive global change Start exploring ➡️ http://lite.spr.ly/6... #UKKW2025 #PodocyteConference2025

Dialysis facilities face unique challenges during disasters. The Humanitarian Kidney Support Initiative module offers dialysis staff practical guidance to maintain essential care during natural or human-made emergencies. Explore and complete the module: bit.ly/3ZzoAMD

⏳ Last days to apply! Early-career nephrologists from LMICs: Apply by June 1 for the ISN Interventional Nephrology Scholarship. 🩺 Hands-on training 🌍 17 global centers 💸 Travel & living costs covered 🔗 Learn more: http://lite.spr.ly/6...

Because #KidneyHealthMatters @theisn.org is advocating for the global community at #WHA78

Do not miss this capacity-building webinar in research curated with love by the @theisn.org young nephrologist committee #ISNyoung with renowned experts in the field

ISN Quiz alert!! 📌HTN remains the leading global contributor to reno cardiovascular death and disability. 📌Take this evidence-based quiz from ISN SoMe team members to assess your knowledge and improve patient care. Here’s the link for the quiz: theisn.outgrow.us/HTN_2025

Happy to share our case based onconephrology web series @isnkidneycare.bsky.social Expand your expertise in complex cancer-related kidney disease cases   - International Society of Nephrology @sabinekaram.bsky.social t.co/J8eU9klFnc

🧰New tools for early ICI-AKI detection! 💧Urine, 🩸 serum, and 📸 imaging markers are changing the game. Protect kidneys 🫘 , save lives!🌱 🔗 doi.org/10.34067/KID... @asnpublications.bsky.social K360 @sabinekaram.bsky.social et al #Nephrology #OncoNephrology #AKI #NephSky #MedSky #NephPearls

Do not miss this webinar to learn about the deaign and appraisal of kidney trials with world experts. Free registration @theisn.org #ISNyoung

Metformin is both safe and effective in advanced CKD with its discontinuation porentially increasing mortality

is contrast nephropathy in the room with us right now? another article showing that contrast nephropathy isn’t a thing I wonder how long these articles will keep getting published, since I kinda thought this was settled 🤷‍♂️ https://www.jem-journal.com/article/S0736-4679(24)00372-X/abstract #EMIMCC

“Thus, the apparent reduction in the incidence of AKI in the PROTECTION trial may be more an ephemera than a meaningful clinical benefit.” Paul Palevsky #NephSky (Also, read the whole thing)

Dr Taler’s approach to resistant HTN. Evaluate for pseudoresistance, always consider clues for secondary HTN and selectively test, ALWAYS check aldo/renin possibly during initial visit ( if no MRA or amiloride), Use longer acting meds, add SGLT if CKD or DM, MRA of course, then other meds depending

Strengthening ties to advance regional and global kidney care: ISN Affiliated societies meet at WCN’25 http://lite.spr.ly/6... #ISNWCN

Growing and learning with young nephrologists worldwide: A message of gratitude, by @sabinekaram.bsky.social @http://lite.spr.ly/6001GDpB, immediate past chair of the ISN Young Nephrologists Committee http://lite.spr.ly/6... #ISNyoung

Stellar lesson of advocacy today given by @cervantes-lily1.bsky.social who makes the impossible happen, so pertinent on #Worldkidneyday

Amazing paper to read for anybody interested in implementation science and equity by @cervantes-lily1.bsky.social

𝗜𝗡𝗦𝗜𝗚𝗛𝗧, our newsletter is out! Read about: • How to get involved in #WorldKidneyDay • ISN Academy Rare Kidney Diseases CME-accredited training • New 12 ISN Fellows • “Growing and learning with young nephrologists worldwide” by @sabinekaram.bsky.social • and more www.theisn.org/news/insight...

#ECNeph Do join us today for an interesting case discussion at 9.30 PM IST @myadla.bsky.social @ferarceamare.bsky.social @theisn.org @dilushiwijay.bsky.social @nephromythri.bsky.social @karnephro.bsky.social @sabinekaram.bsky.social @arvindcanchi.bsky.social @sreejithdr.bsky.social

🚨 #Tweetorial Alert! 🚨 🔬 Rare Kidney Diseases: Unmasking the Zebras in Nephrology! 🦓💡 Join me, Dr. Mythri Shankar, @nephromythri.bsky.social as we explore fascinating, rare kidney diseases—because not every kidney case is a horse! 🏇 Stay tuned! 🧵👇 #NephTwitter #RareKidneyDiseases #MedEd

Serve the date for this webinar that will make primary care physicians master anything related to proteinuria! @theisn.org

PA in Resistant Hypertension: A Hidden Epidemic? 📊 Up to 22% prevalence in resistant hypertension! 📈 Increases with age 😱 Even 11% of normotensives have a high aldosterone signature! 🚨 #NephJC

A new prognostic test incorporates biomarkers and clinical data approved by the FDA to assess the risk of progressive decline in kidney function in individuals with type 2 diabetes and CKD stages G1-3b. bit.ly/JASN0644 #ASNJASN

Cancer diagnosis and prognosis after initiation of hemodialysis: multicenter Japan CANcer and DialYsis (J-CANDY) study academic.oup.com/ckj/article/... @kdjhaveri.bsky.social @ckj-era.bsky.social

Sarees were the highlight of the #ISNWCN congress: bringing women from all over the world in a unique march of love together @theisn.org Thank you #WININDIA

After ACCORD & BPROAD - there will be another large RCT of BP targets in diabetes OPTIMAL Diabetes from Brazil with N = 9500 clinicaltrials.gov/study/NCT040... This one going down to a GFR of 20! h/t Roberto Pecoits-Filho at #ISNWCN - recruitment is complete with results expected in 2026

DID YOU KNOW you can catch up with research highlights from major conferences, including WCN25, on our website? #isnwcn #nephrology #nephsky #kidney

Commentary in @annalsofim.bsky.social ACP journal club on the recent Vukadinovic et al SR on renal denervation Link (🔒) www.acpjournals.org/doi/10.7326/... #hypertension #Nephsky

Kidney health for all in India is practiced through through educating schoolkids and raising awareness at an early age Global Kidney Health Policy Forum @theisn.org #ISNWCN

Unique aspects from the Global Health Kidney Forum @theisn.org #ISNWCN translated into emotional and pertinent cartoons

In January 2025 CJASN @asnpublications.bsky.social : "78% of monogenic causes of kidney disease identified were due to mutations in 1 of 9 genes, encompassing 4 subtypes of CKD." PKD1, PKD2, COL4A3, COL4A4, COL4A5, APOL1, MUC1, UMOD.(3 of my favorites included) pubmed.ncbi.nlm.nih.gov/39792540/

Finally some answers regarding the use of dapagliflozinnin ADPKD

Ready for WCN'25? Download the Congress app. Grab your badge today (2:00–7:00 p.m.) and don’t miss tomorrow’s highlights: Global Kidney Policy Forum, ISN-GKHA Map Launch, Opening Ceremony, and Plenary 1. Share your moments with #ISNWCN and explore activities at the ISN booth! 👋

Combine scientific diversity with indian hospitality and you will get #ISNWCN starting in a few hours!

Yet another proof that the CKDEPI creatinine-cystatin C equation is likely to reflect best mGFR in Cancer patients @asnpublications.bsky.social

On the matter of representation, Andrea Vicelli underlines that not only patients’ cohort should be representative, but also investigators 📍about 20% of trial authors are female 📍<40% of the patients are female #ISNWCN #WomenInNephrology www.kireports.org/article/S246...

Dr. Sethi ⭐️delivered an outstanding lecture at the @glomcon.org fellowship program this morning. By the end of the session, the fellows were asking for another lecture with him.🤍😉 #Nephsky

Feliz dia de los reyes! Great parade to celebrate epiphany in Sitges, Spain

Support them!

How can mathematical modeling improve kidney disease treatment? Anita Layton presents the Stewart Cameron Lecture at WCN’25 ➡️ ow.ly/R3Na50UpuMX #ISNWCN

Genotype-First Analysis in an Unselected Health System–Based Population and Phenotypic Severity of COL4A5 Variants. tl;dr The spectrum of kidney disease in those with COL4A5 variants is broad and under diagnosed. journals.lww.com/jasn/abstrac...

📖 Don't miss our @kireports.bsky.social #ISNFridaySelection: Review of Exercise Interventions to Improve Clinical Outcomes in Non-dialysis Chronic Kidney Disease www.kireports.org/ar...#ISNFridaySelection:#NephSky